Stocks
Blueprint Medicines Corporation (BPMC) R&D US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 331.5 | 326.9 | 601.0 | 477.4 | 427.7 | 345.3 | |||
| Changes by years, y/y, % | +36% | -1% | +84% | -21% | -10% | +11.9% | |||
Blueprint Medicines Corporation. R&D, bln rub
Blueprint Medicines Corporation. R&D, changes, %
Blueprint Medicines Corporation. R&D, sum by quarters, bln rub
Blueprint Medicines Corporation (BPMC) R&D US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D, bln rub | 110.3 | 96.0 | 83.4 | 80.7 | 85.3 | 345.3 | ||
| Changes by years, y/y, % | -14% | -19% | -26% | -27% | -23% | |||
| Changes by quarters, q/q, % | +0% | -13% | -13% | -3% | +6% | |||
